SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%
 

← Persons Index

Sun Piaoyang
Rank #308 · Healthcare

Sun Piaoyang

Pharmaceuticals · China

Net worth$10.9B
Today+$26M
7 days−$219K
30 days+$235M

Net worth, last 30 days

Low $10.5BHigh $11.6B

Biography

Sun Piaoyang is the chairman of Jiangsu Hengrui Pharmaceuticals. He has turned a formerly state-led business into one of China's largest producers of anti-infection and tumor-treating medicines.

He became the head of the state-led company in 1990 when he was 32 years old.

After taking Hengrui public in Shanghai in 2000, Sun led the firm to complete a Hong Kong listing in 2025, raising $1.3 billion.

Sun's wife Zhong Huijuan, also a billionaire, is the chairman and CEO of Hansoh Pharmaceutical Group, a drug maker that listed on the Hong Kong Stock Exchange in 2019.

Their daughter, Sun Yuan, is Hansoh's executive director.

Holdings

CompanyTickerSharesValue
Jiangsu Hengrui Medicine600276-CN1,426,897,000$66.9B
Private assets & other$797M

Public holdings ≈ $66.9B. Holdings may include options and overlap between rows.